NCT04540029View on ClinicalTrials.gov

Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

May 6, 2020

Primary Completion Date

April 30, 2023

Study Completion Date

May 15, 2024

Conditions
Prenatal Stress
Interventions
OTHER

Maternal stress

Prenatal COVID-19-related stress retrospectively self-reported by mothers after delivery.

Trial Locations (1)

27100

IRCCS Mondino Foundation, Pavia

All Listed Sponsors
lead

"IRCCS National Neurological Institute C. Mondino Foundation"

OTHER

NCT04540029 - Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure | Biotech Hunter | Biotech Hunter